The main purpose is to guide the clinical rational use of drugs, reduce adverse drug reactions and reduce the failure of new drug development due to drug toxicity.
Medical In-Vitro Toxicology Testing Market contains market size and forecasts of Medical In-Vitro Toxicology Testing in Global, including the following market information:
- Global Medical In-Vitro Toxicology Testing Market Revenue, 2017-2022, 2023-2028, ($ millions)
- Global top five companies in 2021 (%)
The global Medical In-Vitro Toxicology Testing market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
- The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
- Cell Culture Technology Segment to Reach $ Million by 2028, with a % CAGR in next six years.
- The global key manufacturers of Medical In-Vitro Toxicology Testing include Covance, Bio-Rad Laboratories, QIAGEN, Merck, Thermo Fisher Scientific, Charles River Laboratories and Catalent, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
- We surveyed the Medical In-Vitro Toxicology Testing companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Medical In-Vitro Toxicology Testing Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Medical In-Vitro Toxicology Testing Market Segment Percentages, by Type, 2021 (%)
- Cell Culture Technology
- High Throughput Technology
- Molecular Imaging Technologies
- Omics Technologies
Global Medical In-Vitro Toxicology Testing Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Medical In-Vitro Toxicology Testing Market Segment Percentages, by Application, 2021 (%)
- Pharmaceutical Industry
- Chemical Industry
- Food Industry
- Others
Global Medical In-Vitro Toxicology Testing Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Medical In-Vitro Toxicology Testing Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
- Key companies Medical In-Vitro Toxicology Testing revenues in global market, 2017-2022 (estimated), ($ millions)
- Key companies Medical In-Vitro Toxicology Testing revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Covance
- Bio-Rad Laboratories
- QIAGEN
- Merck
- Thermo Fisher Scientific
- Charles River Laboratories
- Catalent
Industry Market Size
